← Back to Discover
Royalty Pharma Sub-Manager, LLC
Period ended Sep 30, 2026 · Latest filing Nov 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $196,268,588
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CYTOKINETICS, INC · COM · 23282W605 · shares: $64,617,637
- ZENAS BIOPHARMA, INC. · COM · 98937L105 · shares: $64,408,406
- BIOHAVEN LTD · COM · G1110E107 · shares: $39,202,368
- KAILERA THERAPEUTICS · COM · 482931102 · shares: $28,040,177
Reported holdings
4 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CYTOKINETICS, INC | COM | 23282W605 | — | 980,392 shares | $64,617,637 |
| ZENAS BIOPHARMA, INC. | COM | 98937L105 | — | 2,388,150 shares | $64,408,406 |
| BIOHAVEN LTD | COM | G1110E107 | — | 2,936,507 shares | $39,202,368 |
| KAILERA THERAPEUTICS | COM | 482931102 | — | 2,455,357 shares | $28,040,177 |